These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 19099489)
1. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. Nahm MH; Lin J; Finkelstein JA; Pelton SI J Infect Dis; 2009 Feb; 199(3):320-5. PubMed ID: 19099489 [TBL] [Abstract][Full Text] [Related]
2. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Wroe PC; Lee GM; Finkelstein JA; Pelton SI; Hanage WP; Lipsitch M; Stevenson AE; Rifas-Shiman SL; Kleinman K; Dutta-Linn MM; Hinrichsen VL; Lakoma M; Huang SS Pediatr Infect Dis J; 2012 Mar; 31(3):249-54. PubMed ID: 22173142 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009. Rudolph K; Bruce M; Bruden D; Zulz T; Wenger J; Reasonover A; Harker-Jones M; Hurlburt D; Hennessy T Diagn Microbiol Infect Dis; 2013 Mar; 75(3):271-6. PubMed ID: 23276772 [TBL] [Abstract][Full Text] [Related]
4. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong. Ho PL; Chiu SS; Chan MY; Ang I; Chow KH; Lau YL Diagn Microbiol Infect Dis; 2011 Dec; 71(4):327-34. PubMed ID: 22000087 [TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191 [TBL] [Abstract][Full Text] [Related]
6. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249 [TBL] [Abstract][Full Text] [Related]
7. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290 [TBL] [Abstract][Full Text] [Related]
8. The rise and fall of pneumococcal serotypes carried in the PCV era. Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425 [TBL] [Abstract][Full Text] [Related]
9. Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C. Neves FPG; Cardoso NT; Snyder RE; Marlow MA; Cardoso CAA; Teixeira LM; Riley LW Vaccine; 2017 May; 35(21):2794-2800. PubMed ID: 28431817 [TBL] [Abstract][Full Text] [Related]
10. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece. Grivea IN; Tsantouli AG; Michoula AN; Syrogiannopoulos GA Vaccine; 2011 Nov; 29(48):8882-7. PubMed ID: 21963873 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae. Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940 [TBL] [Abstract][Full Text] [Related]
12. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920 [TBL] [Abstract][Full Text] [Related]
13. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015. Kaur R; Casey JR; Pichichero ME Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806 [TBL] [Abstract][Full Text] [Related]
14. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA. McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405 [TBL] [Abstract][Full Text] [Related]
15. Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine. Paulo AC; Sá-Leão R PLoS One; 2017; 12(4):e0176723. PubMed ID: 28453533 [TBL] [Abstract][Full Text] [Related]
16. Increased nasopharyngeal carriage of serotypes 6A, 6C, and 6D Streptococcus pneumoniae after introduction of childhood pneumococcal vaccination in Hong Kong. Ip M; Chau SS; Lai LS; Ma H; Chan PK; Nelson EA Diagn Microbiol Infect Dis; 2013 Jun; 76(2):153-7. PubMed ID: 23541419 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Finkelstein JA; Huang SS; Daniel J; Rifas-Shiman SL; Kleinman K; Goldmann D; Pelton SI; DeMaria A; Platt R Pediatrics; 2003 Oct; 112(4):862-9. PubMed ID: 14523178 [TBL] [Abstract][Full Text] [Related]
18. Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7. Hanke CR; Grijalva CG; Chochua S; Pletz MW; Hornberg C; Edwards KM; Griffin MR; Verastegui H; Gil AI; Lanata CF; Klugman KP; Vidal JE Pediatr Infect Dis J; 2016 Apr; 35(4):432-9. PubMed ID: 26974749 [TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Ozdemir H; Ciftçi E; Durmaz R; Güriz H; Aysev AD; Karbuz A; Gökdemir R; Acar B; Nar Ötgün S; Ertek M; Köse SK; Ince E Eur J Pediatr; 2014 Mar; 173(3):313-20. PubMed ID: 24046219 [TBL] [Abstract][Full Text] [Related]
20. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Cooper D; Yu X; Sidhu M; Nahm MH; Fernsten P; Jansen KU Vaccine; 2011 Sep; 29(41):7207-11. PubMed ID: 21689707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]